Skip to main content
Equibles

Brad Bailey

Genmab A/S (GMAB)

Equibles does not estimate personal net worth.

Get an email with a short summary when Genmab A/S publishes a filing, an earnings call transcript or a press release.

Get GMAB alerts

About Brad Bailey

Brad Bailey has spoken on 2 earnings calls across 1 company, most recently for Genmab A/S on May 7, 2026. Genmab A/S is classified in the Biotechnology industry within the Healthcare sector.

Brad Bailey on recent calls

“Our proprietary portfolio is off to a strong start here in 2026. Sales for the quarter totaled $176 million, representing 43% growth compared to Q1 last year.”
Other, Earnings conference call (announced in 6-K) ·
“2025 marked another successful year for our commercialization team. We maintained leading positions for our proprietary brands globally, and we made important progress evolving into a wholly owned model, fueling our long-term growth engine.”
Other, Genmab A/S Q4 FY2025 Earnings Call ·

Affiliation history

Company network

Recent activity